Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses

被引:55
作者
Xie, Yong [1 ,2 ]
Deng, Wen [1 ]
Sun, Hongxiang [1 ]
Li, Duo [2 ]
机构
[1] Zhejiang Univ, Coll Anim Sci, Hangzhou 310029, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Biosyst Engn & Food Sci, Hangzhou 310029, Zhejiang, Peoples R China
关键词
Platycodon grandiflorum; platycodin D2; haemolysis; adjuvant; cytokines; transcription factors;
D O I
10.1016/j.intimp.2008.04.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Platycodin D2 (PD2), a saponin isolated from the root of Platycodon grandiflorum, was evaluated for its haemolytic activity and adjuvant potential on the cellular and humoral immune responses to ovalbumin (OVA) in ICR mice. The HD(50) values of PD2 and Quit A were 18.57 +/- 1.37 and 5.76 +/- 0.23 mu g/ml against 0.5% rabbit red blood cell, respectively, implicating the less haemolytic activity for PD2 than Quit A. ICR mice were immunized subcutaneously with OVA 100 mu g alone or with OVA 100 mu g dissolved in saline containing Alum (200 mu g), or PD2 (25, 50, 75 or 100 mu g) on Day 1 and 15. Two weeks later (Day 28), concanavalin A (Con A)-, lipopolysaccharide (LPS-) and OVA-stimulated splenocyte proliferation and OVA-specific antibodies in serum were measured. PD2 significantly enhanced the Con A-, LPS-, and OVA-induced splenocyte proliferation in the OVA-immunized mice (P<0.05, P<0.01 or P<0.001). OVA-specific IgG, IgG1, IgG2a, and IgG2b antibody titers in serum were also significantly enhanced by PD2 compared with OVA control group (P<0.05, P<0.01 or P<0.001). Further, the effects of PD2 on mRNA expression of cytokines and transcription factors in Con A-stimulated mice splenocytes were evaluated by RT-PCR analysis. PD2 significantly promoted the mRNA expression of cytokines IL-2, IFN-gamma, IL-4, and IL-10 and transcription factors T-bet and GATA-3 (P<0.05, P<0.01 or P<0.001). In conclusion, the results suggest that PD2 could be safety used as adjuvant eliciting Th1 and Th2 immune responses. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:1143 / 1150
页数:8
相关论文
共 39 条
[1]   Vaccine adjuvants revisited [J].
Aguilar, J. C. ;
Rodriguez, E. G. .
VACCINE, 2007, 25 (19) :3752-3762
[2]   Development of immunoadjuvants for immunotherapy of cancer [J].
Azuma, I ;
Seya, T .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (07) :1249-1259
[3]   T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3 [J].
Chakir, H ;
Wang, HP ;
Lefebvre, DE ;
Webb, J ;
Scott, FW .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 278 (1-2) :157-169
[4]  
Chapman PB, 2000, CLIN CANCER RES, V6, P874
[5]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[6]   QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans [J].
Evans, TG ;
McElrath, MJ ;
Matthews, T ;
Montefiori, D ;
Weinhold, K ;
Wolff, M ;
Keefer, MC ;
Kallas, EG ;
Corey, L ;
Gorse, GJ ;
Belshe, R ;
Graham, BS ;
Spearman, PW ;
Schwartz, D ;
Mulligan, MJ ;
Goepfert, P ;
Fast, P ;
Berman, P ;
Powell, M ;
Francis, D .
VACCINE, 2001, 19 (15-16) :2080-2091
[7]  
FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511
[8]   INTERLEUKIN-12 PROFOUNDLY UP-REGULATES THE SYNTHESIS OF ANTIGEN-SPECIFIC COMPLEMENT-FIXING IGG2A, IGG2B AND IGG3 ANTIBODY SUBCLASSES IN-VIVO [J].
GERMANN, T ;
BONGARTZ, M ;
DLUGONSKA, H ;
HESS, H ;
SCHMITT, E ;
KOLBE, L ;
KOLSCH, E ;
PODLASKI, FJ ;
GATELY, MK ;
RUDE, E .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (03) :823-829
[9]   Qualitative and quantitative determination of ten major saponins in Platycodi Radix by high performance liquid chromatography with evaporative light scattering detection and mass spectrometry [J].
Ha, Young Wan ;
Na, Yun-Cheol ;
Seo, Jung-Ju ;
Kim, Soo-Na ;
Linhardt, Robert J. ;
Kim, Yeong Shik .
JOURNAL OF CHROMATOGRAPHY A, 2006, 1135 (01) :27-35
[10]   Mechanisms of stimulation of the immune response by aluminum adjuvants [J].
HogenEsch, H .
VACCINE, 2002, 20 :S34-S39